At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 31, 2026 at 20:00 ET
Three corporate insiders at Apogee Therapeutics, including the CEO, CFO, and CMO, sold shares totaling $1.77 million over a 7-day period, with the majority of the activity coming from CEO Michael Thomas Henderson's $1.47 million open-market sale. This represents coordinated selling by top executives, though the total value remains below 0.1% of the company's $6.0B market cap.
- Insider cluster involves three C-suite executives: CEO, CFO, and CMO.
- Total value of sales: $1.77 million, all via open-market transactions (S).
- CEO Michael Thomas Henderson sold $1.47 million of shares, accounting for 83% of the total cluster value.
- Sales occurred between 2026-04-01 and 2026-04-08, indicating concentrated timing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access